Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Ipsen    IPN   FR0010259150

IPSEN

(IPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Ipsen : Q3 2020 Sales Conference Call – Thursday, October 22, 2020

10/22/2020 | 06:45am EST

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the Group's Q3 2020 sales on:

Date: Thursday, October 22, 2020

Time: Conference call and webcast - 2:30pm CEST / 8:30 EST

Webcast Link:https://engage.vevent.com/rt/ipsen~ipsen-q3-sales-2020

Participants should dial in to the call approximately 15 minutes prior to its start.

No live presentation will be organized at Ipsen's headquarters.

Participants can register for the call on the link below:

http://emea.directeventreg.com/registration/3185126

Conference ID: 3185126

Disclaimer

Ipsen SA published this content on 22 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 October 2020 10:44:05 UTC


© Publicnow 2020
All news about IPSEN
11/25EACD 2020 : How the use of functional assessments in clinical trials provides me..
PU
11/18ALERT : New purchases in the Investor Europe portfolio
10/27IPSEN : Disclosure of Transactions in Own Shares Between 10/19/2020 And 10/20/20..
BU
10/23IPSEN : delivers sales growth in the first nine months of 2020 despite the impac..
AQ
10/22IPSEN : Q3 2020 Sales Conference Call – Thursday, October 22, 2020
PU
10/22IPSEN : announces sales growth over the first 9 months of 2020
PU
10/22IPSEN : delivers sales growth in the first nine months of 2020 despite the impac..
PU
10/22IPSEN : Delivers Sales Growth in the First Nine Months of 2020 Despite the Impac..
BU
10/22IPSEN : 3rd quarter results
CO
10/20IPSEN : Disclosure of Transactions in Own Shares between 10/12/2020 and 10/16/20..
BU
More news
Financials
Sales 2020 2 654 M 3 174 M 3 174 M
Net income 2020 461 M 552 M 552 M
Net Debt 2020 717 M 857 M 857 M
P/E ratio 2020 14,5x
Yield 2020 1,28%
Capitalization 6 608 M 7 901 M 7 904 M
EV / Sales 2020 2,76x
EV / Sales 2021 2,43x
Nbr of Employees 5 807
Free-Float 42,0%
Chart IPSEN
Duration : Period :
Ipsen Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IPSEN
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 96,49 €
Last Close Price 80,00 €
Spread / Highest target 41,3%
Spread / Average Target 20,6%
Spread / Lowest Target 1,25%
EPS Revisions
Managers
NameTitle
David G. Loew Chief Executive Officer & Director
Marc M. P. de Garidel Non-Executive Chairman
Aymeric Le Chatelier Chief Financial Officer & Executive Vice President
Aidan Murphy Executive Vice President-Technical Operations
Howard Mayer Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
IPSEN1.14%7 858
JOHNSON & JOHNSON-1.50%378 244
ROCHE HOLDING AG-3.47%285 939
NOVARTIS AG-11.58%203 854
PFIZER INC.-1.59%203 048
MERCK & CO., INC.-11.97%202 555